Nov 7, 2019
The experimental medication for Alzheimer's called Aducanumab by Biogen improved cognition substantially in the participants of a Phase 3 Clinical Trial.
seen from China
seen from United States
seen from Türkiye
seen from Russia
seen from United States
seen from Türkiye
seen from Netherlands
seen from China
seen from China
seen from United States
seen from United States
seen from South Africa
seen from United States
seen from Germany
seen from Malaysia
seen from United States
seen from China
seen from United States
seen from Poland
seen from United States
The experimental medication for Alzheimer's called Aducanumab by Biogen improved cognition substantially in the participants of a Phase 3 Clinical Trial.
7 out of 8 participants in a clinical trial have shown impressive improvements in cognitive performance after 2 months of treatment with the device.